298 related articles for article (PubMed ID: 34060430)
41. Molecular update of β-thalassemia mutations in the Syrian population: identification of rare β-thalassemia mutations.
Jarjour RA; Murad H; Moasses F; Al-Achkar W
Hemoglobin; 2014; 38(4):272-6. PubMed ID: 24828949
[TBL] [Abstract][Full Text] [Related]
42. Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling.
Abdullah UYH; Ibrahim HM; Mahmud NB; Salleh MZ; Teh LK; Noorizhab MNFB; Zilfalil BA; Jassim HM; Wilairat P; Fucharoen S
Hemoglobin; 2020 May; 44(3):184-189. PubMed ID: 32586164
[TBL] [Abstract][Full Text] [Related]
43. Effect of Assorted Globin Haplotypes and α-Thalassemia on the Clinical Heterogeneity of Hb S-β-Thalassemia.
Dash PM; Sahu PK; Patel S; Mashon RS; Kharat KR; Mukherjee MB
Hemoglobin; 2018 Jul; 42(4):236-242. PubMed ID: 30486691
[TBL] [Abstract][Full Text] [Related]
44. Molecular characterization of a β-thalassemia intermedia patient presenting inferior vena cava thrombosis: interaction of the β-globin erythroid Krüppel-like factor binding site mutation with Hb E and α(+)-thalassemia.
Prajantasen T; Teawtrakul N; Fucharoen G; Fucharoen S
Hemoglobin; 2014; 38(6):451-3. PubMed ID: 25370867
[TBL] [Abstract][Full Text] [Related]
45. First Report on the Coinheritance of α-Thalassemia and a Rare β-Thalassemia Compound Heterozygosity for the IVS-I-I(G>A)/IVS-II-705(T>G) Mutations in a Syrian Family.
Murad H; Moassas F
Hemoglobin; 2019 Jan; 43(1):66-68. PubMed ID: 30843739
[TBL] [Abstract][Full Text] [Related]
46. Compound Heterozygosity for Hb Alperton (HBB: c.407C>T) and IVS-I-5 (G>C) (HBB: c.92+5G>C) Mutations Presenting as a Moderate Anemia in an Indian Family.
Godbole KG; Ramachandran A; Karkamkar AS; Dalal AB
Hemoglobin; 2018 Mar; 42(2):141-142. PubMed ID: 29651865
[TBL] [Abstract][Full Text] [Related]
47. A Triple-Heterozygous β-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel β
Liao J; Li Q; Ling LQ; Liu CN; Huang XB; Zhou J
Hemoglobin; 2022 Jul; 46(4):249-252. PubMed ID: 35575165
[TBL] [Abstract][Full Text] [Related]
48. Severe Thalassemia Caused by Hb Zunyi [β147(HC3)Stop→Gln;
Su Q; Chen S; Wu L; Tian R; Yang X; Huang X; Chen Y; Peng Z; Chen J
Hemoglobin; 2019 Jan; 43(1):7-11. PubMed ID: 31084366
[TBL] [Abstract][Full Text] [Related]
49. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
[TBL] [Abstract][Full Text] [Related]
50. Molecular Characterization of β-Thalassemia Mutations in Central Vietnam.
Doro MG; Casu G; Frogheri L; Persico I; Triet LPM; Hoa PTT; Hoang NH; Pirastru M; Mereu P; Cucca F; Masala B
Hemoglobin; 2017 Mar; 41(2):96-99. PubMed ID: 28671035
[TBL] [Abstract][Full Text] [Related]
51. Hb Midnapore [β53(D4)Ala→Val; HBB: c.161C>T]: A Novel Hemoglobin Variant with a Structural Abnormality Associated with IVS-I-5 (G>C) (HBB: c.92+5G>C) Found in a Bengali Indian Family.
Panja A; Chowdhury P; Basu A
Hemoglobin; 2016 Sep; 40(5):300-303. PubMed ID: 27690257
[TBL] [Abstract][Full Text] [Related]
52. Thalassemia in Malaysia.
Alwi ZB; Syed-Hassan SR
Hemoglobin; 2022 Jan; 46(1):45-52. PubMed ID: 35950577
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the HBB: c.*233G > C Variant: No Evidence of a β-Thalassemic Phenotype.
Smith DL; Mitui M; Park JY; Luu HS; Timmons CF
Hemoglobin; 2016; 40(1):25-8. PubMed ID: 26524961
[TBL] [Abstract][Full Text] [Related]
54. [Genotype of thalassemia genes and the polymorphism of β- globin gene in Cantonese].
Liu L; Jiang WY; Xu SY; Chen J; Chen LM; Tian QH; Wang JC
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):595-9. PubMed ID: 23906453
[TBL] [Abstract][Full Text] [Related]
55. The Spectrum of β-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
Farra C; Abdouni L; Souaid M; Awwad J; Yazbeck N; Abboud M
Hemoglobin; 2021 Nov; 45(6):365-370. PubMed ID: 33947296
[TBL] [Abstract][Full Text] [Related]
56. β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
Kluge ML; Hoyer JD; Swanson KC; Oliveira JL
Hemoglobin; 2014; 38(4):292-4. PubMed ID: 24986053
[TBL] [Abstract][Full Text] [Related]
57. Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β
Abdaoui W; Benouareth DE; Djenouni A; Renoux C; Grifi F; Gouri A; Athamnia F; Benalioua M; Joly P
Hemoglobin; 2019; 43(4-5):223-228. PubMed ID: 31603010
[TBL] [Abstract][Full Text] [Related]
58. Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the Eastern Province of Saudi Arabia.
Akhtar MS; Qaw F; Borgio JF; Albuali W; Suliman A; Nasserullah Z; Al-Jarrash S; Al-Ali A
Hemoglobin; 2013; 37(1):65-73. PubMed ID: 23297837
[TBL] [Abstract][Full Text] [Related]
59. Rare β-Globin Gene Mutations in Pakistan.
Hussain A; Ahmed S; Ali N; S Mailk H; Anees M; Chuahdry AH; Ahmed P
Hemoglobin; 2017 Mar; 41(2):100-103. PubMed ID: 28670940
[TBL] [Abstract][Full Text] [Related]
60. Thalassemia and Hemoglobinopathies in an Ethnic Minority Group in Northern Vietnam.
Anh TM; Sanchaisuriya K; Kieu GN; Tien DN; Thu HBT; Sanchaisuriya P; Fucharoen S; Fucharoen G; Schelp FP
Hemoglobin; 2019; 43(4-5):249-253. PubMed ID: 31581858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
